A rapid health technology assessment of recombinant human thrombopoietin in the treatment of primary immune thrombocytopenia and chemotherapy-induced thrombocytopenia

HAN Jing; MEN Peng; LIU Wei; ZHAI Suo-di

doi:10.3969/j.issn.1003-3734.2020.05.020

Home>Articles>A rapid health technology assessment of recombinant human thrombopoietin in the treatment of primary immune thrombocytopenia and chemotherapy-induced thrombocytopenia

DOI: 10.3969/j.issn.1003-3734.2020.05.020

A rapid health technology assessment of recombinant human thrombopoietin in the treatment of primary immune thrombocytopenia and chemotherapy-induced thrombocytopenia

HAN Jing

MEN Peng

LIU Wei

ZHAI Suo-di

Machine-generated Keywords：

Publication Date：2020-03-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 589-594 )

Chinese Journal of New Drugs

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2020,29(5)